
Adlai Nortye Raises $100 Million In Series D Financing, Co-led By SDIC Fund Management And Tigermed
Adlai Nortye Ltd. (hereinafter referred to as "Adlai Nortye"), a global biopharmaceutical company focused on developing innovative oncology drugs, today announced the completion of $100 million Series D financing round. Co-led by SDIC ...